These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8164353)

  • 21. Use of plasma renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
    Baumstark ME; Nussberger J; Boretti FS; Baumstark MW; Riond B; Reusch CE; Sieber-Ruckstuhl NS
    J Vet Intern Med; 2014; 28(5):1471-8. PubMed ID: 25274440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquorice, growth retardation and Addison's disease.
    Doeker BM; Andler W
    Horm Res; 1999; 52(5):253-5. PubMed ID: 10844416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects.
    Lottermoser K; Hertfelder HJ; Wehling M; Schiermeyer B; Vetter H; Düsing R
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):357-60. PubMed ID: 11967823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating interdialytic hyperkalemia with fludrocortisone.
    Imbriano LJ; Durham JH; Maesaka JK
    Semin Dial; 2003; 16(1):5-7. PubMed ID: 12535291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin, angiotensin, corticosteroids, and electrolyte balance in Addison's disease.
    Brown JJ; Fraser R; Lever AF; Robertson JI; James VH; McCusker J; Wynn V
    Q J Med; 1968 Jan; 37(145):97-118. PubMed ID: 4297956
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cortineff in the treatment of Addison's disease in a 5-year-old child].
    Korczowski R; Nizankowska-Blaz T
    Pediatr Pol; 1972 Jul; 47(7):893-6. PubMed ID: 5054580
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of Addison's disease].
    Stoppoloni G; Prisco F; Donadio E; Palmieri A; Tolone C
    Pediatria (Napoli); 1978 Mar; 86(1):103-8. PubMed ID: 683790
    [No Abstract]   [Full Text] [Related]  

  • 29. Replacement therapy in Addison's disease.
    Løvås K; Husebye ES
    Expert Opin Pharmacother; 2003 Dec; 4(12):2145-9. PubMed ID: 14640913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement.
    Oelkers W; L'age M
    Klin Wochenschr; 1976 Jul; 54(13):607-12. PubMed ID: 940296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mineralocorticoid activity on transtubular potassium gradient, urinary [K]/[Na] ratio, and fractional excretion of potassium.
    Chacko M; Fordtran JS; Emmett M
    Am J Kidney Dis; 1998 Jul; 32(1):47-51. PubMed ID: 9669423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthostatic hypotension and chronic fatigue syndrome.
    Baschetti R
    JAMA; 2001 Mar; 285(11):1441-2; author reply 1443. PubMed ID: 11255414
    [No Abstract]   [Full Text] [Related]  

  • 34. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
    Sherman DS; Kass CL; Fish DN
    Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Addison's disease and pregnancy].
    Gundersen T
    Tidsskr Nor Laegeforen; 1979 Jan; 99(2):87-8. PubMed ID: 419488
    [No Abstract]   [Full Text] [Related]  

  • 36. [The action of 9 alpha-fluorohydrocortisone on some aspects of water-electrolyte metabolism in animals].
    Bogdanov VI; Osipov YuY ; Shashkov VS; Survorov NN
    Farmakol Toksikol; 1978; 41(4):441-5. PubMed ID: 668870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudotumor cerebri: a presenting manifestation of Addison's disease.
    Condulis N; Germain G; Charest N; Levy S; Carpenter TO
    Clin Pediatr (Phila); 1997 Dec; 36(12):711-3. PubMed ID: 9415840
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of aldosterone antagonists in healthy man.
    McInnes GT; Shelton JR; Ramsay LE
    Methods Find Exp Clin Pharmacol; 1982; 4(1):49-71. PubMed ID: 7045549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure with fludrocortisone in Addison's disease.
    Bhattacharyya A; Tymms DJ
    J R Soc Med; 1998 Aug; 91(8):433-4. PubMed ID: 9816363
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence that patients with Addison's disease are undertreated with fludrocortisone.
    Smith SJ; MacGregor GA; Markandu ND; Bayliss J; Banks RA; Prentice MG; Dorrington-Ward P; Wise P
    Lancet; 1984 Jan; 1(8367):11-4. PubMed ID: 6140341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.